Celiac Disease-Pipeline Review, H1 2016 Celiac Disease-Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Celiac Disease-Pipeline Review, H1 2016’, provides an overview of the Celiac Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Celiac Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule… Read More »
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016 Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016 GlobalData’s clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016” provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. Report includes an overview of trial numbers and… Read More »
Rabies-Pipeline Review, H1 2016 Rabies-Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Rabies-Pipeline Review, H1 2016’, provides an overview of the Rabies pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rabies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also… Read More »
Hemophilia B-Pipeline Review, H1 2016 Hemophilia B-Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hemophilia B-Pipeline Review, H1 2016’, provides an overview of the Hemophilia B pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hemophilia B, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule… Read More »
Chikungunya-Pipeline Review, H1 2016 Chikungunya-Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chikungunya-Pipeline Review, H1 2016’, provides an overview of the Chikungunya pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chikungunya, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also… Read More »
NCPHS ESC-Viamonte Senior Living Complex-California-Construction Project Profile The “NCPHS/ESC-Viamonte Senior Living Complex-California-Construction Project Profile” contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The “NCPHS/ESC-Viamonte Senior Living Complex-California-Construction Project Profile” is part of Timetric’s… Read More »
Mild Cognitive Impairment-Pipeline Review, H1 2016 Mild Cognitive Impairment-Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mild Cognitive Impairment-Pipeline Review, H1 2016’, provides an overview of the Mild Cognitive Impairment pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mild Cognitive Impairment, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of… Read More »
Chronic Heart Failure-Pipeline Review, H1 2016 Chronic Heart Failure-Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chronic Heart Failure-Pipeline Review, H1 2016’, provides an overview of the Chronic Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Heart Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of… Read More »
Waldenstrom Macroglobulinemia-Pipeline Review, H1 2016 Waldenstrom Macroglobulinemia-Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia-Pipeline Review, H1 2016’, provides an overview of the Waldenstrom Macroglobulinemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Waldenstrom Macroglobulinemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule… Read More »
Chagas Disease American Trypanosomiasis-Pipeline Review, H1 2016 Chagas Disease (American Trypanosomiasis)-Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis)-Pipeline Review, H1 2016’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chagas Disease (American Trypanosomiasis), complete with analysis by stage of development, drug target, mechanism of… Read More »
